The membrane fusion enigma: SNAREs, Sec1/Munc18 proteins, and their accomplices—guilty as charged?

J Rizo, TC Südhof - Annual review of cell and developmental …, 2012 - annualreviews.org
Neurotransmitter release is governed by proteins that have homo-logs in most types of
intracellular membrane fusion, including the Sec1/Munc18 protein Munc18-1 and the …

VPS10P-domain receptors—regulators of neuronal viability and function

TE Willnow, CM Petersen, A Nykjaer - Nature Reviews Neuroscience, 2008 - nature.com
VPS10P-domain receptors, such as SORLA and sortilin, constitute a recently identified class
of type-1 receptors that are expressed in neurons. Family members are multifunctional …

Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein

OM Andersen, J Reiche, V Schmidt… - Proceedings of the …, 2005 - National Acad Sciences
sorLA (sorting protein-related receptor) is a type-1 membrane protein of unknown function
that is expressed in neurons. Its homology to sorting receptors that shuttle between the …

Long noncoding RNAs and Alzheimer's disease

Q Luo, Y Chen - Clinical interventions in aging, 2016 - Taylor & Francis
Long noncoding RNAs (lncRNAs) are typically defined as transcripts longer than 200
nucleotides. lncRNAs can regulate gene expression at epigenetic, transcriptional, and …

An intronic ncRNA-dependent regulation of SORL1 expression affecting Aβ formation is upregulated in post-mortem Alzheimer's disease brain samples

E Ciarlo, S Massone, I Penna… - Disease models & …, 2013 - journals.biologists.com
Recent studies indicated that sortilin-related receptor 1 (SORL1) is a risk gene for late-onset
Alzheimer's disease (AD), although its role in the aetiology and/or progression of this …

Amyloidogenic processing of β-amyloid precursor protein in intracellular compartments

KS Vetrivel, G Thinakaran - Neurology, 2006 - AAN Enterprises
Trafficking and proteolytic processing of amyloid precursor protein (APP) have been the
focus of numerous investigations in the past two decades, since the identification of Aβ as …

Statins reduce amyloid-β production through inhibition of protein isoprenylation

SM Ostrowski, BL Wilkinson, TE Golde… - Journal of Biological …, 2007 - ASBMB
Epidemiological evidence suggests that long term treatment with hydroxymethylglutaryl-CoA
reductase inhibitors, or statins, decreases the risk for developing Alzheimer disease (AD) …

SorLA/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1

V Schmidt, A Sporbert, M Rohe, T Reimer… - Journal of Biological …, 2007 - ASBMB
SorLA has been recognized as a novel sorting receptor that regulates trafficking and
processing of the amyloid precursor protein (APP) and that represents a significant risk …

Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK

S Pedrini, TL Carter, G Prendergast… - PLoS …, 2005 - journals.plos.org
Background Statins are widely used cholesterol-lowering drugs that act by inhibiting
HMGCoA reductase, the rate-limiting enzyme in cholesterol biosynthesis. Recent evidence …

The role of non-coding RNAs in Alzheimer's disease: from regulated mechanism to therapeutic targets and diagnostic biomarkers

Y Zhang, Y Zhao, X Ao, W Yu, L Zhang… - Frontiers in aging …, 2021 - frontiersin.org
Alzheimer's disease (AD) is a progressive neurodegenerative disorder. AD is characterized
by the production and aggregation of beta-amyloid (Aβ) peptides, hyperphosphorylated tau …